Erika Berman Rosenzweig, M.D., is an internationally prominent physician in her field, with a reputation as an outstanding clinician, teacher, and researcher. An expert in the field of pulmonary hypertension, Dr. Rosenzweig currently serves as vice chair for clinical/translational research in the Department of Pediatrics and director of the Adult and Pediatric Pulmonary Hypertension Comprehensive Care Center at Columbia University Medical Center/NewYork-Presbyterian Hospital. She also holds a faculty appointment as a professor of pediatrics in medicine at Columbia University.

Education

• M.D., Mount Sinai School of Medicine
• Residency in Pediatrics, Columbia University
• Fellowship in Pediatric Cardiology and Pulmonary Hypertension, Columbia University
• Board-certified in pediatric cardiology and adult congenital heart disease

 

Research

Dr. Rosenzweig’s research has been widely published and she has served as site principal investigator on more than 50 clinical drug trials, devoting remarkable efforts toward clinical research on the study of novel treatments of pulmonary arterial hypertension, as well as novel approaches to mechanical support for patients with end-stage pulmonary hypertension. She currently serves as director of the Pediatric Pulmonary Hypertension Network of North America, as a Pediatric Task Force advisor for the 2024 World Symposium on pulmonary hypertension, and as immediate past chair of the Pulmonary Vascular Disease Interdisciplinary Network Steering Committee for the International Society for Heart and Lung Transplantation.

Memberships and Affiliations

She has also been an active member of the Pulmonary Hypertension Association (PHA), currently serving as a distinguished faculty advisor to the Scientific Leadership Council. She previously served on the PHA Board of Trustees, as chair of the Scientific Leadership Council, and as editor-in-chief of the medical journal Advances in Pulmonary Hypertension.